Status:
COMPLETED
Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
To investigate a potential pharmacokinetic interaction between SKI-606 and ketoconazole when co-administered.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead ECG.
Exclusion
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2007
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00434486
Start Date
March 1 2007
End Date
March 1 2007
Last Update
September 12 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philadelphia, Pennsylvania, United States, 19148